According to reports, senior federal health officials have advised the Biden administration to put its vaccine booster plan on hold until further research is complete.
Dr. Janet Woodcock, Acting Commissioner of the Food and Drug Administration and Dr. Rochelle Valensky, director of the Centers for Disease Control and Infection, said in a briefing with the federal government that further inquiries are needed before they can offer a round of advice. The third dose proceeds.
According to the new York Times, he said it also needs to be established whether it is possible to give people a different dose from a different manufacturer than their first two doses, or even if all people need a third vaccination.
Dr Woodcock and Dr Valensky reportedly sought more data before reaching any final decision. Moderna’s FDA approval is believed to be lacking in data, while data for the Johnson & Johnson vaccine is not.
The discussion is said to have taken place during a meeting with White House pandemic coordinator Jeff Gents. It is unknown how Mr Giants reacted, says Time.
“We’ve always said we’ll follow the science, and that’s all part of the process that’s going on now,” White House spokesman Chris Meagher told the newspaper. He stressed that he was seeking “full review and approval” for the booster shot plan from the FDA and CDC before launching it.
The plan for booster shots was announced by President Biden last month, eight months after a full-fledged vaccine against Kovid. It is due to start on 20 September, and Mr Biden said he and First Lady Jill Biden would get their doses as soon as possible.
On September 2, Dr. Anthony Fauci, Mr. Biden’s senior medical adviser and director of the National Institute of Allergy and Infectious Diseases, voiced his support behind a possible third dose.
“From my own experience as an immunologist, I would not be at all surprised that an adequate, complete regimen for vaccination would likely be three doses,” he said.
Initially the objective of the scheme is to provide third dose which includes elderly, health workers and care home residents. The inspiration for the plan came from Israel, the first jurisdiction to deliver a third dose, starting with over 60 people. Although, Time It also reports that the FDA is interested in looking at “raw data” from the program, which is in place so far.
Questions have been circulated in the medical community regarding the need for a unilateral third dose. Some senior vaccine regulators have resigned from the FDA in protest.
Dr. Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia and a member of the FDA’s advisory panel Time: “There is no compelling reason to take a third dose”.
Various studies have shown that vaccines provide strong protection despite weakening over time.
“We have also seen data from Israel that there is a decrease in immunity and it starts affecting what used to be 100% against hospitalization. Now, after a period of six months, the low 90s and mid to high 80s are happening,” explained Pfizer CEO Albert Boerla. CNBC In July.
However, despite this downside, being vaccinated still offers benefits, especially in light of the delta variant. data from CDC It turns out that unconnected people are at much higher risk from covid. Because the rate of infection in unvaccinated people is five times higher than in vaccinated people.
Furthermore, it shows that hospitalization rates are also higher among unvaccinated people. One in 24.9 per 100,000 people is hospitalized, while only one in 100,000 people vaccinated is admitted.
Credit: www.independent.co.uk / COVID-19